Smad1 plays an essential role in bone development and postnatal bone formation

Osteoarthritis and Cartilage

Volumn 19, Issue 6, 2011, Pages 751-762

  Wang, M ^a   Jin, H ^a,b   Tang, D ^a   Huang, S ^c   Zuscik, M J ^a   Chen, D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BMP signaling; Chondrocyte; Conditional knockout; Osteoblast; Smad1

Indexed keywords

ALKALINE PHOSPHATASE; SMAD1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HISTOLOGY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; POSTNATAL GROWTH; PRIORITY JOURNAL; STAINING;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; BONE DEVELOPMENT; COLLAGEN TYPE II; GENE EXPRESSION PROFILING; MICE; MICE, TRANSGENIC; SMAD1 PROTEIN; TRABECULAR MESHWORK; X-RAY MICROTOMOGRAPHY;

EID: 79955952951     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2011.03.004     Document Type: Article

References (44)

1. Shum L., Coleman C.M., Hatakeyama Y., Rocky T.S. Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today 2003, 69:102-122.
2. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89(5):747-754.
3. Zelzer E., Olsen B.R. The genetic basis for skeletal diseases. Nature 2003, 423:343-348.
4. Yang X., Karsenty G. Transcription factors in bone: developmental and pathological aspects. Trends Mol Med 2002, 8:340-345.
5. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
6. Mori-Akiyama Y., Akiyama H., Rowitch D.H., de Crombrugghe B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 2003, 100:9360-9365.
7. Kobayashi H., Gao Y.-H., Ueta C., Yamaguchi A., Komori T. Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 2000, 273:630-636.
8. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
9. Ochiai T., Shibukawa Y., Nagayama M., Mundy C., Yasuda T., Okabe T., et al. Indian hedgehog roles in post-natal TMJ development and organization. J Dent Res 2010, 89(4):349-354.
10. Zhu M., Tang D., Wu Q., Hao S., Chen M., Xie C., et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res 2009, 24(1):12-21.
11. Yoon B.S., Pogue R., Ovchinnikov D.A., Yoshii I., Mishina Y., Behringer R.R., et al. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 2006, 133:4667-4678.
12. Haas A.R., Tuan R.S. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation 1999, 64:77-89.
13. Cao X., Chen D. The BMP signaling and in vivo bone formation. Gene 2005, 357:1-8.
14. Hoodless P.A., Haerry T., Abdollah S., Stapleton M., O'Connor M.B., Attisano L., et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85(4):489-500.
15. Tremblay K.D., Dunn N.R., Robertson E. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001, 128:3609-3621.
16. Lechleider R.J., Ryan J.L., Garrett L., Eng C., Deng C., Wynshaw-Boris A., et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001, 240:157-167.
17. Kaufman M.H. The Atlas of Mouse Development 1995, Academic Press, London, UK, pp. 1-8.
18. Retting K.N., Song B., Yoon B.S., Lyons K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136(7):1093-1104.
19. Hoess R.H., Abremski K. Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system. J Mol Biol 1985, 181:351-362.
20. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 2000, 26:99-109.
21. Kwan K.M. Conditional alleles in mice: practical considerations for tissue-specific knockouts. Genesis 2002, 32:49-62.
22. Huang S., Tang B., Usoskin D., Lechleider R.J., Jamin S.P., Li C., et al. Conditional knockout of the Smad1 gene. Genesis 2002, 32:76-79.
23. Ovchinnikov D.A., Deng J.M., Ogunrinu G., Behringer R.R. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 2000, 26:145-146.
24. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001, 128:1253-1264.
25. Schwenk F., Baron U., Rajewsky K. A Cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 1995, 23:5080-5081.
26. Dacquin R., Starbuck M., Schinke T., Karsenty G. Mouse alpha 1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 2002, 224:245-251.
27. Rossert J.A., Eberspaecher H., de Crombrugghe B. Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol 1995, 129:1421-1432.
28. Zhao M., Harris S.E., Horn D., Geng Z., Nishimura R., Mundy G.R., et al. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 2002, 157:1049-1060.
29. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002, 17:15-25.
30. Kalajzic Z., Liu P., Kalajzic I., Du Z., Braut A., Mina M., et al. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 2002, 31:654-660.
31. Zhao M., Qiao M., Harris S.E., Oyajobi B.O., Mundy G.R., Chen D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 2004, 279:12854-12859.
32. Jiang Y., Zhao J., Mitlak B.H., Wang O., Genant H.K., Eriksen E.F. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 2003, 18:1932-1941.
33. Feng J.Q., Xing L., Zhang J., Zhao M., Horn D., Chan J., et al. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 2003, 278:29130-29135.
34. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998, 142:295-305.
35. Yan Y., Tang D., Chen M., Huang J., Xie R., Jonason J.H., et al. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci 2009, 122(Pt 19):3566-3578.
36. Abzhanov A., Rodda S.J., McMahon A.P., Tabin C.J. Regulation of skeletogenic differentiation in cranial dermal bone. Development 2007, 134:3133-3144.
37. Chen M., Zhu M., Awad H., Li T.F., Sheu T.J., Boyce B.F., et al. Inhibition of beta-catenin signaling causes defects in postnatal cartilage development. J Cell Sci 2008, 121(Pt 9):1455-1465.
38. Yoshida Y., Tanaka S., Umemori H., Minowa O., Usui M., Ikematsu N., et al. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 2000, 103:1085-1097.
39. Usui M., Yoshida Y., Yamashita T., Tsuji K., Isao I., Yamamoto T., et al. Enhancing effect of Tob deficiency on bone formation is specific to bone morphogenetic protein-induced osteogenesis. J Bone Miner Res 2002, 17:1026-1033.
40. Devlin R.D., Du Z., Pereira R.C., Kimble R.B., Economides N., Jorgetti V., et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 2003, 144:1972-1978.
41. Wu X.B., Li Y., Schneider A., Yu W., Rajendren G., Iqbal J., et al. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 2003, 112:924-934.
42. Winkler D.G., Sutherland M.K., Geoghegan J.C., Yu C., Hayes T., Skonier J.E., et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 2003, 22:6267-6276.
43. Mishina Y., Starbuck M.W., Gentile M.A., Fukuda T., Kasparcova V., Seedor J.G., et al. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 2004, 279:27560-27566.
44. Kamiya N., Ye L., Kobayashi T., Lucas D.J., Mochida Y., Yamauchi M., et al. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res 2008, 23:2007-2017.